NAD+ and Aging: NR, NMN and Human Evidence

In this article
NAD+ is a coenzyme that cells use in energy metabolism and other essential processes. Interest in anti-aging research centers on how that metabolism changes over time, and whether compounds used to make NAD+ can help maintain function. Understanding the molecule is a good place to start before interpreting a supplement claim.
What does NAD+ do?
Nicotinamide adenine dinucleotide is a long name for a molecule with a central cellular job. In oxidation-reduction, or redox, reactions it accepts and transfers electrons as nutrients are processed. NAD+ and its reduced form, NADH, help connect those reactions with the cell’s energy needs.
NAD+ also supplies enzymes involved in processes such as DNA repair and responses to cellular stress. Xie and colleagues’ 2020 review describes this wider network, including energy metabolism, inflammation and stress resistance. This is why the molecule attracts attention across several fields of aging research.
Why investigate aging?
The study of NAD+ began with yeast fermentation more than a century ago. Research later connected its metabolism with aging and disease pathways in cells and animals. Imai and Guarente’s 2014 review examined NAD+ and sirtuins, enzymes involved in cellular regulation; Fang and colleagues’ 2017 review explored mechanisms and their possible translation into treatments.
Aging research follows changes in particular tissues and biological systems. Reported NAD+ changes depend on what is measured and in whom, so there is no single percentage that describes everyone’s decline. The important clinical question is whether an intervention improves health or function for the people taking it.
The wider field also includes approaches as different as platelet-rich plasma, glutathione and NAD+ precursors. Each has its own mechanism and evidence. Here, we’ll stay with NAD+ and the compounds the body can use to produce it.
What are NR and NMN?
Nicotinamide riboside, or NR, and nicotinamide mononucleotide, or NMN, are two NAD+ precursors studied as supplements. A precursor is a building block that enters a pathway for making another molecule. The body also uses forms of niacin and the amino acid tryptophan in NAD+ metabolism.
Foods contribute these dietary building blocks. The examples in this discussion include eggs, fish, meat, dairy foods, vegetables and whole grains. Eating a varied diet is a different intervention from taking a measured supplement in a trial, even when both involve related nutrients.
NR, NMN and NAD+ itself are different compounds. Their delivery, uptake and conversion are part of the research, along with the amount reaching different tissues. She and colleagues’ 2021 review discusses precursor pharmacology across experimental and clinical settings. Identifying the compound being tested makes a comparison much clearer.
Fasting, calorie restriction and exercise also appear in this research as ways of changing energy availability or demand. They give scientists ways to investigate how metabolic pathways respond. For everyday decisions about eating and activity, overall health and individual needs matter alongside an interesting mechanism.
A human NR trial provides a concrete example
In Martens and colleagues’ 2018 trial, healthy middle-aged and older adults took NR and placebo for six weeks each, in a randomized, double-blind crossover design. Twenty-four people completed both phases.
NR was well tolerated over the study period, and no serious adverse events were reported. The researchers found roughly 60% higher NAD+ in peripheral blood mononuclear cells—a group of immune cells—in the NR condition than with placebo. That laboratory analysis was available for twenty-one participants.
The team also explored cardiovascular measures. Blood-pressure differences for the overall group did not remain statistically significant after adjustment for multiple comparisons, and the findings prompted questions for further trials. The established result here is short-term NR tolerability and a change in NAD+ metabolism, with longer-term health and lifespan outcomes still requiring study.
What should readers take from the research?
NAD+ connects energy production with cellular maintenance, making it a useful research target. A supplement’s effects need to be followed from the compound taken, through the biological change, to an outcome that matters to the person. The same study may answer one step much more clearly than another.
When reading a claim, look for the actual compound, participants, duration and outcome. A trial of NR in healthy older adults answers a different question from an NMN experiment in animals or a study involving a particular disease. Those details help put encouraging results in perspective without losing sight of why the research is interesting.
As clinical work develops, it can clarify which approaches are useful, for whom and over what period. For now, keep the distinction between an essential cellular molecule and a proven anti-aging treatment clear when discussing options with an appropriate healthcare professional.
References
Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017). NAD+ in aging: Molecular mechanisms and translational implications. Trends in Molecular Medicine, 23(10), 899–916. https://doi.org/10.1016/j.molmed.2017.08.001
Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471. https://doi.org/10.1016/j.tcb.2014.04.002
Shade C. (2020). The science behind NMN-A stable, reliable NAD+ Activator and anti-aging molecule. Integrative medicine (Encinitas, Calif.), 19(1), 12–14.
She, J., Sheng, R., & Qin, Z. H. (2021). Pharmacology and potential implications of nicotinamide adenine dinucleotide precursors. Aging and disease, 12(8), 1879–1897. https://doi.org/10.14336/AD.2021.0523
Xie, N., Zhang, L., Gao, W. et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Sig Transduct Target Ther 5, 227 (2020). https://doi.org/10.1038/s41392-020-00311-7
Martens, C. R., et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, 1286. https://doi.org/10.1038/s41467-018-03421-7
